What is Rho?
Founded in 1984 and headquartered near Chapel Hill, North Carolina, Rho operates as a specialized contract research organization (CRO). The firm provides comprehensive clinical research services that span the entire drug development lifecycle, from early-phase trials to post-market surveillance. With decades of industry experience, Rho has established a reputation for technical precision and scientific rigor, positioning itself as a critical intermediary in the global healthcare innovation ecosystem. Its market position is defined by a commitment to high-quality data management and regulatory compliance, which are essential for bringing life-saving therapies to market efficiently.
How much funding has Rho raised?
Rho has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Rho
PPP
Public-Private Partnership
What's next for Rho?
With the recent influx of capital, Rho is well-positioned to scale its enterprise-level operations and enhance its technological stack. The strategic deployment of these funds will likely focus on optimizing clinical trial management systems and expanding the firm's footprint in emerging therapeutic areas. As the pharmaceutical industry continues to demand more agile and data-driven research solutions, Rho's ability to integrate advanced analytics with traditional CRO services will be a key driver of its future growth. The company is expected to prioritize long-term partnerships with global biopharma leaders, further cementing its status as a cornerstone of the clinical research industry.
See full Rho company page
